2019
DOI: 10.1038/s41467-019-13342-8
|View full text |Cite
|
Sign up to set email alerts
|

Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing

Abstract: DNA base editors have enabled genome editing without generating DNA double strand breaks. The applications of this technology have been reported in a variety of animal and plant systems, however, their editing specificity in human stem cells has not been studied by unbiased genome-wide analysis. Here we investigate the fidelity of cytidine deaminase-mediated base editing in human induced pluripotent stem cells (iPSCs) by whole genome sequencing after sustained or transient base editor expression. While base-ed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
42
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 56 publications
(46 citation statements)
references
References 48 publications
(41 reference statements)
4
42
0
Order By: Relevance
“…Importantly, all treated samples were confirmed to be bi-allelically edited at the on-target B2M locus, indicating receipt of active base editor or Cas9. Consistent with previous results from ABE7.10-d-treated animals in embryo injection mouse experiments 37,38,45,46 , we found no detectable increase (P-value = 0.911, one-sided Wilcoxon-Mann-Whitney U test, Supplementary Table 26 and Supplementary Table 27) in genome-wide A-to-G mutations upon treatment with ABE7.10-d (Fig. 4b, 4c and Supplementary Fig.…”
Section: Off Target Analyses Of Abe8s In Mammalian Cellssupporting
confidence: 92%
See 2 more Smart Citations
“…Importantly, all treated samples were confirmed to be bi-allelically edited at the on-target B2M locus, indicating receipt of active base editor or Cas9. Consistent with previous results from ABE7.10-d-treated animals in embryo injection mouse experiments 37,38,45,46 , we found no detectable increase (P-value = 0.911, one-sided Wilcoxon-Mann-Whitney U test, Supplementary Table 26 and Supplementary Table 27) in genome-wide A-to-G mutations upon treatment with ABE7.10-d (Fig. 4b, 4c and Supplementary Fig.…”
Section: Off Target Analyses Of Abe8s In Mammalian Cellssupporting
confidence: 92%
“…27). Concurrently, we identified a statistically significant increase in C-to-T mutations in BE4treated samples compared to untreated controls (P-value = 0.010, one-sided Wilcoxon-Mann-Whitney U test, Supplementary Table 26), consistent with previous reports 37,38,45,46 . We observed no statistically significant increase in A->G% mutation rates across the ABE8.17-m, ABE8.20-m or Cas9 groups when compared to untreated samples (P-value = 0.375, 0.643, and 0.27, respectively, one-sided Wilcoxon-Mann-Whitney U test, Fig.…”
Section: Off Target Analyses Of Abe8s In Mammalian Cellssupporting
confidence: 90%
See 1 more Smart Citation
“…4a). However, we identified a statistically significant increase in the ratio of C-to-T mutations following cellular treatment with BE4-rAPOBEC1 (as previously reported [6][7][8]21 ), BE4-PpAPOBEC1, and BE4-RrA3F F130L compared with untreated controls (P value = 0.018, 0.026, and 0.018, respectively, one-sided Wilcoxon-Mann-Whitney U test) ( Fig. 4a).…”
Section: Be4-rra3fsupporting
confidence: 85%
“…Whole genome sequencing (WGS) experiments were performed on base-editor-treated HEK293T cells grown by clonally expanding single cells ( Supplementary Fig. 15a) 21 . We compared the frequency of CBE-induced mutations in cells where base editors were delivered as either plasmid or mRNA.…”
Section: Be4-rra3fmentioning
confidence: 99%